- 8.1.2025
- Blog
Freedom to Heal: What It Means And Why We’re Fighting For It
At VETS, we believe that healing is a right, not a privilege. That’s what we mean by Freedom to Heal. It’s not just a phrase. It’s a promise. And it’s the driving force behind everything we do.
- 8.1.2025
- Stanford Research
Neurology Advisor: Magnesium–Ibogaine May Be Beneficial for Combat Veterans With TBI
Reports that magnesium–ibogaine may benefit combat veterans with TBI based on observed resting-state brain-wave changes. The piece focuses on altered cortical oscillations and links those signals to psychiatric and cognitive outcomes.
Fox Nation: Ibogaine: The Fight of a Lifetime
“Ibogaine: The Fight of a Lifetime” is a Fox Nation news segment highlighting the experiences of Special Operations veterans pursuing psychedelic-assisted therapy to address traumatic brain injury and PTSD.
Fox News: Will Cain Country with Marcus and Amber Capone
Amber and Marcus Capone joined Will Cain on Fox's Will Cain Country to discuss VETS, ibogaine-assisted therapy, and the fight to bring this treatment home to veterans who need it.
- 7.24.2025
- Stanford Research
News-Medical: Ibogaine treatment shows major breakthrough for veterans with brain injuries
Covers the Nature Mental Health paper on magnesium–ibogaine effects on cortical oscillations and neural complexity. It highlights the study as evidence that ibogaine may produce measurable brain-function changes in veterans with TBI.
- 7.23.2025
- News
Advocates want NC legislature to consider rules around psychedelics for PTSD treatment
Advocates in North Carolina are urging lawmakers to support Senate Bill 568, which would create a task force to explore safe, regulated access to psychedelic-assisted therapy for PTSD—especially for veterans. While not legalizing psychedelics, the bill aims to prepare the state for future FDA approval through infrastructure planning and veteran-focused care.
- 7.22.2025
- Stanford Research
U.S. Medicine: Magnesium–Ibogaine Therapy Could Offer Treatment Option for TBI
Summarizes the Nature Mental Health study for a veteran/clinical audience, emphasizing rapid changes in brain activity after treatment. It includes comments from lead author Jennifer Lissemore about why the team studied ibogaine’s effects on brain function.
- 7.16.2025
- News
RFK Jr. and other Trump officials embrace psychedelics after FDA setback
RFK Jr. and former Trump officials are backing psychedelic therapies like MDMA and ibogaine, pushing for FDA approval amid growing bipartisan interest. The article highlights veteran voices, including VETS' Marcus Capone, advocating for access despite safety concerns.
- 7.15.2025
- Stanford Research
Military.com: Veteran Executive Order a Win for Ibogaine, But More Research Needed
Mentions the newer MRI findings showing increased cortical thickness after magnesium–ibogaine treatment. It places the study in the context of veteran advocacy and the need for more rigorous ibogaine research.
- 7.8.2025
- Blog
A New Hope for Healing: Psilocybin Clinical Trial Now Open to Veterans
Thanks to the recent passage of SB5263, Washington State is developing a robust legal framework for Washington residents over the age of 21 to access psilocybin services. With it comes a clinical trial designed specifically for U.S. veterans.